Oklahoma City, Okla. and Greensboro, N.C. tops in flu activity
Oklahoma City, Okla. and Greensboro, N.C. were the top cities for flu activity in Walgreens Flu Index for Week Ending February 23.
Pharmacy
Lupin launches generic minocycline hydrochloride ER tablets
Lupin announced the launch of minocycline hydrochloride extended-release tablets USP 55mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Rite Aid rolls out prescription drug safety program in Ohio schools
In an effort to help address adolescent drug abuse and misuse in Ohio, The Rite Aid Foundation is bringing the Prescription Drug Safety program, an innovative digital course about prescription drug abuse prevention, to Akron-area high schools.
Pharmacy champion McMorris Rodgers leads letter to HHS on DIR reform
Rep. Cathy McMorris Rodgers (R, Wash.
PCMA launches new advertising campaign
The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly proposed regulation that would eliminate
SDM drives slight gain in Loblaw’s Q4 sales
Shoppers Drug Mart propelled a slight uptick in parent Loblaw Cos.’ fourth quarter sales. SDM posted 1.9% same-store sales growth for the quarter ended December 29 compared to a year earlier, with pharmacy same-store sales growth of 0.6% and front store same-store sales growth of 2.8%.
Hy-Vee acquires Weber & Judd Pharmacies
Hy-Vee announced Monday that it has acquired the business of all Weber & Judd pharmacies in Minnesota. Weber & Judd has served the Rochester, Minnesota, area since 1862. “Weber & Judd has been an exemplary provider of pharmacy care for more than 150 years. Combining Weber & Judd with our Hy-Vee
Rite Aid names Bulkley CEO of EnvisionRxOptions
Rite Aid Corp. announced that Ben Bulkley, an established executive with more than 20 years’ experience in health care and technology, has been named chief executive officer of EnvisionRxOptions, a pharmacy benefit management (PBM) company and wholly owned subsidiary of Rite Aid.
QS/1 gears up for giving at PDS Conference
QS/1’s passion to give community pharmacy the resources to succeed in today’s marketplace will be on display at the annual PDS Super-Conference here this week. QS/1 will continue a tradition of honoring pharmacy staff who give so much to their communities.
Dr. Reddy’s announces the re-launch of its buprenorphine and naloxone sublingual film
Dr. Reddy’s Laboratories announced this week the re-launch of its buprenorphine and naloxone sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone (buprenorphine and naloxone) sublingual film, in the U.S. market.
Insilico, Teva team to apply predictive Digital Twins for biopharmaceutical production
Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. announced an agreement to apply Insilico’s technology for predictive biomanufacturing to create and implement more efficient production processes of Teva’s biopharmaceutical therapeutics.
NPC releases new study for improving patient-reported measures in oncology
The National Pharmaceutical Council (NPC) and Discern Health Thursday released a study that analyzes the landscape of available patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs) in oncology and offers recommendations for filling gaps in measures and removing barrier
Abbott and Novo Nordisk to provide integrated digital solution to people with diabetes using insulin
Abbott and Novo Nordisk announced Wednesday a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii c
Wyoming, Oklahoma and Montana see flu activity gains in Walgreens Index
DEERFIELD, Ill. – Wyoming, Oklahoma and Montana had flu activity gains in Walgreens Flu Index for the week ending February 16, 2019.
Teva introduces a generic of Acanya
Teva Pharmaceuticals announces the introduction and availability of clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. This product is AB rated and bioequivalent to Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel. Teva Pharmaceuticals USA, Inc.
Glenmark to spin off its innovation business into a new company in the U.S.
Glenmark Pharmaceuticals announced that its board of directors has given an in-principle approval to spin off the innovation business into a new company in the U.S.